Gul Dolen is a pioneering neuroscientist who's investigating the “critical periods” of psychedelics, including studies where she's given MDMA — also known as “Molly” — to octopuses.
Intelligent. Optimistic. Curious.
Science
Behavioral neurologist Michael Trimble takes us on an evolutionary journey to unpack one of the few things that make Homo sapiens unique — we cry emotional tears.
In the years when psychedelic science had been shut down, Amanda Feilding helped jump-start research into altered states of mind. Today, she's in her 80s and remains active in psychedelic research with her Beckley Foundation.
Can neuroscience explain what happens to the brain on psychedelics? And even if we map the brain while it’s tripping, does that tell us why these experiences can be so transformative?
Neuroscientist Christof Koch has pioneered the scientific investigation of consciousness. Recently, he had a mind-blowing experience — both terrifying and ecstatic — with 5-MeO-DMT, also known as toad venom.
David Nutt believes psychedelics will revolutionize the treatment of mental disorders. A neuropsychopharmacologist at Imperial College London, he says psychedelic therapy can help people resolve their buried traumas.
For years, Robin Carhart-Harris dreamed of using brain scans to study people on LSD. He’s gone on to conduct pioneering research on psilocybin, and he’s formulated a theory of the "entropic brain" to explain what happens during psychedelic experiences.
The rock icon explains why she’s fascinated by psychedelics as a promising treatment for addiction, a path for spiritual exploration, and a source of creativity.
Pages
